MedTrace Logo

Single Dose Partial Breast Radiotherapy

NCT00944528 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-10-27

Study results available
· View outcomes & findings →

Summary

This study seeks to determine the maximum tolerated dose of a single-dose partial breast radiation given before lumpectomy using a radiosurgery technique. Lumpectomy will be performed within 3 weeks (+/- 1 week) of completing radiation.

Conditions

Interventions

RADIATION

Radiosurgery

Single dose or radiation in 15Gy, 18Gy or 21Gy

Sponsors & Collaborators

Principal Investigators

  • Rachel Blitzblau, MD PhD · Duke University Medical Center, Dept of Radiation Oncology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-28
Primary Completion
2016-04-04
Completion
2023-03-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00944528 on ClinicalTrials.gov